AMPHETAMINE RESPONSE AND RELAPSE RISK AFTER DEPOT NEUROLEPTIC DISCONTINUATION

被引：37

作者：

ANGRIST, B ^{[1
]}

PESELOW, E ^{[1
]}

RUBINSTEIN, M ^{[1
]}

WOLKIN, A ^{[1
]}

ROTROSEN, J ^{[1
]}

机构：

[1] NYU MED CTR, DEPT PSYCHIAT, NEW YORK, NY 10016 USA

来源：

PSYCHOPHARMACOLOGY | 1985年 / 85卷 / 03期

关键词：

D O I：

10.1007/BF00428187

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：277 / 283

页数：7

共 23 条

[1] PARTIAL IMPROVEMENT IN NEGATIVE SCHIZOPHRENIC SYMPTOMS AFTER AMPHETAMINE [J].

ANGRIST, B ;

PESELOW, E ;

RUBINSTEIN, M ;

CORWIN, J ;

ROTROSEN, J .

PSYCHOPHARMACOLOGY, 1982, 78 (02) :128-130

[2] DIFFERENTIAL-EFFECTS OF AMPHETAMINE AND NEUROLEPTICS ON NEGATIVE VS POSITIVE SYMPTOMS IN SCHIZOPHRENIA [J].

ANGRIST, B ;

ROTROSEN, J ;

GERSHON, S .

PSYCHOPHARMACOLOGY, 1980, 72 (01) :17-19

[3]

ANGRIST B, 1981, ADV BIOSCI, V31, P49

[4]

BROWN WA, 1981, AM J PSYCHIAT, V138, P237

[5] MOLECULAR PATHOLOGY OF SCHIZOPHRENIA - MORE THAN ONE DISEASE PROCESS [J].

CROW, TJ .

BRITISH MEDICAL JOURNAL, 1980, 280 (6207) :66-68

[6]

DELAY J, 1947, P ROY SOC MED, V42, P491

[7] Observations on benzedrine [J].

Guttmann, E ;

Sargant, W .

BMJ-BRITISH MEDICAL JOURNAL, 1937, 1937 :1013-1015

[8]

Guy W., 1976, ECDCEU ASSESSMENT MA

[9]

Hope JM, 1951, DIS NERV SYST, V12, P67

[10]

JANOWSKY DS, 1973, ARCH GEN PSYCHIAT, V28, P185

← 1 2 3 →